Trial Profile
A Phase 2 Study of TRK-130 in Patients With Overactive Bladder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 May 2016
Price :
$35
*
At a glance
- Drugs Naltalimide (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Therapeutic Use
- Sponsors Toray
- 23 May 2016 New trial record